The Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test.
10.4046/trd.2011.71.4.271
- Author:
Yu Eun KIM
1
;
Sang Su LEE
;
Cha Young KIM
;
Seung Hun LEE
;
Su Jin LIM
;
Yu Ji CHO
;
Yi Yeong JEONG
;
Ho Cheol KIM
;
Young Sil HWANG
;
Jong Deog LEE
Author Information
1. Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju, Korea. ljd8611@empal.com
- Publication Type:Original Article
- Keywords:
Body Mass Index;
Pulmonary Disease, Chronic Obstructive;
Disease Progression;
Quality of Life
- MeSH:
Ambulatory Care Facilities;
Animals;
Body Mass Index;
Cats;
Disease Progression;
Dyspnea;
Humans;
Male;
Medical Records;
Outpatients;
Pulmonary Disease, Chronic Obstructive;
Quality of Life;
Spirometry
- From:Tuberculosis and Respiratory Diseases
2011;71(4):271-277
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: A chronic obstructive pulmonary disease (COPD) assessment test (CAT) has recently been developed as a short and simple method for assessing the quality of life in COPD patients. The object of this study was to assess the usefulness of the Korean version of the CAT for assessing COPD patients in an outpatient clinic. METHODS: The study included 60 COPD patients in a stable state from an outpatient clinic. The authors investigated the frequency of acute exacerbation during aprevious year through reviewing medical records. We evaluated the spirometry test, a 6-min walk distance test, and obtained the MMRC dyspnea scale, the Korean version of the CAT, and the BODE index at the time of visit. To assess the usefulness of the CAT, correlations between the CAT and other methods were evaluated. RESULTS: The mean age of patients was 68.3+/-8.6 years and 95% of patients were male. There was a significant correlation between the CAT score and FEV1% (r=-0.323, p=0.012), the frequency of acute exacerbation (r=0.292, p=0.024), the MMRC dyspnea scale (r=0.554, p<0.001), the BODE index (r=0.380, p=0.003), and 6 MWD (r=-0.372, p=0.004). The mean CAT score increased according to the GOLD stage (stage 1, 10.7+/-4.5; stage 2, 13.1+/-7.9; stage 3, 16.3+/-6.2; stage 4, 16.5+/-14.8; p=0.746). CONCLUSION: The CAT was shown to be useful for the assessment of COPD severity. Therefore, the CAT is an easily applied and simple method for assessing COPD severity in an outpatient clinic.
